LEADERSHIP TEAM

The leadership team of PBM Pharmaceuticals has a proven track record in the industry.

PBM Pharmaceuticals contracts for state-of-the-art manufacturing and distribution systems while maintaining the highest quality standards. The management team of PBM Pharmaceuticals has a proven track record in the industry with a broad knowledge base from manufacturing through retail distribution.

  Jack Schramm - President of PBM Pharmaceuticals

  Jack Schramm is the executive vice president of PBM Products   business development, the president of PBM Pharmaceuticals, and   chairman of PBM (Guangzhou) Nutritionals Co.

  Presently, Mr. Schramm's diverse activities include exploring business   development ideas with an emphasis on pharmaceuticals and   business acquisitions.

  Before joining PBM, Mr. Schramm held several senior management executive positions with different firms and has extensive management expertise in negotiations, distribution, research, and U.S. Food and Drug Administration approvals.

Mr. Schramm is a graduate of New York University's Stern School of Business, where he received a BS in economics.

  Jim McGrath - Executive VP, regulatory & product development

  Jim McGrath is the executive vice president of regulatory affairs and   product development for PBM Pharmaceuticals, where he oversees the   development and U.S. Food and Drug Administration approval of   innovative pharmaceutical and nutritional products.

  Before joining PBM, Mr. McGrath held several key management   positions in the areas of product development, technical services,   quality assurance, and regulatory affairs. He has more than 35 years   of experience in the pharmaceutical industry, working for companies such as Wyeth, Rugby-Darby, Circa Pharmaceutical, and NutraMax Products.

Mr. McGrath attended the Wharton executive program at the University of Pennsylvania and is a graduate of New York University, where he earned a BS in chemical engineering.